• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

986
82
61
58
47

COUNTRY

56
19
10
7
5

CATEGORIES

  • 85
  • 124
  • 66
  • 65
  • 37
  • 36
  • 12
  • 12
  • 12
  • 18

PRICE

551
816
1,695
2,678

PUBLISHED

27
292
660
2,678

PRODUCT TYPE

2,574
84
12
7
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Rituxan-Drug Insights,2014 Rituxan-Drug Insights,2014 - Product Thumbnail Image

Rituxan-Drug Insights,2014

“Rituxan - Drug Insights, 2014” provides Rituxan marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management  - Product Thumbnail Image

Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management

Cancer diagnostics based on measuring biomarkers in tissue samples has already in the past decade provided revolutionary advances in diagnosis, prognosis, and therapy selection. A major drawback of...

February 2015
FROM
Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management - Product Thumbnail Image

Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management

Cancer diagnostics based on measuring biomarkers in tissue samples has already in the past decade provided revolutionary advances in diagnosis, prognosis, and therapy selection. A major drawback of...

February 2015
FROM

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics

Summary The report “Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics”, provides in-depth analysis of the...

January 2015
FROM
The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations) The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations) - Product Thumbnail Image

The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations)

The maturation of IVD markets in developed countries has IVD companies casting their nets in developing countries where rising incomes and standards of living are anticipated to spark a new health consciousness...

January 2015
FROM

Esophageal Cancer - Pipeline Review, H1 2015

Esophageal Cancer - Pipeline Review, H1 2015 Summary This, ‘Esophageal Cancer - Pipeline Review, H1 2015’, provides an overview of the Esophageal Cancer’s therapeutic pipeline. This report provides...

January 2015
FROM

Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015

Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015 Summary This, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015’, provides an overview of the Metastatic Adenocarcinoma...

January 2015
FROM

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2015

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2015 Summary This, ‘Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy Induced...

January 2015
FROM

Metastatic Melanoma - Pipeline Review, H1 2015

Metastatic Melanoma - Pipeline Review, H1 2015 Summary This, ‘Metastatic Melanoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline. This report...

January 2015
FROM

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015 Summary This, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015’, provides an overview of the B-Cell Chronic Lymphocytic...

January 2015
FROM

Mantle Cell Lymphoma - Pipeline Review, H1 2015

Mantle Cell Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline. This report...

January 2015
FROM

Fibrosarcoma - Pipeline Review, H1 2015

Fibrosarcoma - Pipeline Review, H1 2015 Summary This, ‘Fibrosarcoma - Pipeline Review, H1 2015’, provides an overview of the Fibrosarcoma’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2015

Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2015 Summary This, ‘Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2015’, provides an overview of the Opioid-Induced Constipation (OIC)’s...

January 2015
FROM

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015 Summary This, ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Large Cell...

January 2015
FROM

Head And Neck Cancer - Pipeline Review, H1 2015

Head And Neck Cancer - Pipeline Review, H1 2015 Summary This, ‘Head And Neck Cancer - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer’s therapeutic pipeline. This report...

January 2015
FROM

Synovial Sarcoma - Pipeline Review, H1 2015

Synovial Sarcoma - Pipeline Review, H1 2015 Summary This, ‘Synovial Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Synovial Sarcoma’s therapeutic pipeline. This report provides...

January 2015
FROM

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015 Summary This, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Squamous Non-Small Cell Lung...

January 2015
FROM

Rectal Cancer - Pipeline Review, H1 2015

Rectal Cancer - Pipeline Review, H1 2015 Summary This, ‘Rectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Rectal Cancer’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Refractory Multiple Myeloma - Pipeline Review, H1 2015

Refractory Multiple Myeloma - Pipeline Review, H1 2015 Summary This, ‘Refractory Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic...

January 2015
FROM

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2015

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2015 Summary This, ‘Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2015’, provides an overview of the Human papillomavirus...

January 2015
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)